On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Lennart Mucke is recognized for his pioneering discoveries in research on Alzheimer’s disease and related disordersAwards News Release Neurological Disease Mucke Lab
Katie Pollard is recognized by the American Institute for Medical and Biological Engineering for her pioneering creation and use of statistical research toolsAwards Data Science and Biotechnology Pollard Lab